drugset / Trial / NCT00630487

Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency

NCT00630487

Phase 3 Terminated 9 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will investigate the effect on growth hormone replacement in patients with isolated growth hormone deficiency on body composition, especially visceral fat mass.

Timeline

Start
2008-05
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.2 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.3 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.4 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 0.5 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic

Indications